Page last updated: 2024-12-07
7-oxodihydrokarounidiol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
7-oxodihydrokarounidiol: structure given in first source; isolated from the seeds of Tricosanthes kirilowii [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 122881 |
MeSH ID | M0206709 |
Synonyms (9)
Synonym |
---|
7-oxydihydrokarounidiol |
(3r,4ar,6bs,8as,11r,12ar,12bs,14bs)-3-hydroxy-11-hydroxymethyl-4,4,6b,8a,11,12b,14b-heptamethyl-1,3,4,4a,5,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14b-octadecahydro-2h-picen-6-one |
7-oxodihydrokarounidiol |
(3r,4ar,6as,6bs,8as,11r,12ar,14bs)-3-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,3,4a,5,7,8,9,10,12,12a,13,14-dodecahydro-1h-picen-6-one |
143183-47-5 |
7-oxo-dc-friedo-olean-8-ene-3alpha,29-diol |
d:c-friedooleanan-8-en-7-one, 3,29-dihydroxy-, (3alpha,20alpha)- |
3-hydroxy-11-(hydroxymethyl)-4,4,6b,8a,11,12b,14b-heptamethyl-1,3,4,4a,5,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14b-octadecahydropicen-6(2h)-one |
DTXSID20931766 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |